Sanofi backs immunology startup, which raises $183M Series C for lead drug’s pivotal trialnews2025-10-22T11:00:41+00:00October 22nd, 2025|Endpoints News|
Elevara raises $70M to test a breast cancer approach in rheumatoid arthritisnews2025-10-21T23:01:30+00:00October 21st, 2025|Endpoints News|
Eli Lilly backs anti-aging biotech NewLimit in $45M raisenews2025-10-20T09:00:12+00:00October 20th, 2025|Endpoints News|
Exclusive: Sid Mukherjee’s Faeth nets $25M for endometrial cancer studynews2025-10-19T09:01:24+00:00October 19th, 2025|Endpoints News|
Megarounds make a comeback as biotech starts to reboundnews2025-10-17T14:00:14+00:00October 17th, 2025|Endpoints News|
British startup Genomics launches business to help drug developersnews2025-10-16T19:34:15+00:00October 16th, 2025|Endpoints News|
Connecticut biotech Veradermics gets $150M for Phase 3 trials of oral Rogainenews2025-10-16T11:30:36+00:00October 16th, 2025|Endpoints News|
Chicago biotech EVOQ pens $500M autoimmune pact with Sanofinews2025-10-16T10:07:32+00:00October 16th, 2025|Endpoints News|
Adcytherix raises €104M Series A to back new ADC drugnews2025-10-16T09:00:55+00:00October 16th, 2025|Endpoints News|
Mark Pruzanski joins Alentis as CEO after leading Intercept and Versanisnews2025-10-15T11:00:15+00:00October 15th, 2025|Endpoints News|
